These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29673884)

  • 1. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer.
    Li HX; Sun XY; Yang SM; Wang Q; Wang ZY
    Pathol Res Pract; 2018 May; 214(5):655-660. PubMed ID: 29673884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
    Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
    Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Zhu D; Sun Y; Zhang D; Dong M; Jiang G; Zhang X; Zhou J
    Oncol Rep; 2018 Aug; 40(2):589-598. PubMed ID: 29845255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.
    Zhou J; Shen W; He X; Qian J; Liu S; Yu G
    Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma.
    Sun QK; Zhu JY; Wang W; Lv Y; Zhou HC; Yu JH; Xu GL; Ma JL; Zhong W; Jia WD
    Med Oncol; 2014 Jan; 31(1):786. PubMed ID: 24297309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
    Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Ochiai T
    Oncol Rep; 2007 Oct; 18(4):867-71. PubMed ID: 17786348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RPS24c Isoform Facilitates Tumor Angiogenesis
    Wang Y; Wu Y; Xiao K; Zhao Y; Lv G; Xu S; Wu F
    Curr Mol Med; 2020; 20(5):388-395. PubMed ID: 31797757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer.
    Yu W; Wu J; Ning ZL; Liu QY; Quan RL
    Med Sci Monit; 2018 Apr; 24():2259-2270. PubMed ID: 29656298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer.
    Gu A; Jie Y; Yao Q; Zhang Y; Mingyan E
    Reprod Sci; 2017 Feb; 24(2):291-299. PubMed ID: 27368877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
    Fang Y; Sun B; Wang J; Wang Y
    Gene; 2019 May; 699():37-42. PubMed ID: 30851425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
    Peng L; Wang R; Shang J; Xiong Y; Fu Z
    Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence.
    Fang Y; He J; Janssen HLA; Wu J; Dong L; Shen XZ
    J Dig Dis; 2018 Mar; 19(3):155-169. PubMed ID: 29377617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
    Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
    Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxiredoxin1 promotes cell proliferation, migration and invasion of colorectal cancer via p38MAPK signaling.
    Cong N; Huang W; Yuan JP; Li GZ; Zhai GS; Li BS
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1922-1928. PubMed ID: 29687844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
    Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
    Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.